Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-059640

Options or other derivatives

  • Chief Medical Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jones Jeffrey Alan · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +300,000 300,000 D
Loading xslF345X05/ownership.xml…